Chonluten (20mg) Research Peptide: An EDG Tripeptide for Respiratory & Anti‑Inflammatory Studies

If your research investigates pulmonary epithelial biology, inflammatory signalling pathways, or the molecular mechanisms of tissue bioregulation, Chonluten (20mg) research peptide offers a precisely defined synthetic tool. Also known as the EDG tripeptide (Glu‑Asp‑Gly) or T‑34, Chonluten belongs to the Khavinson family of short peptide bioregulators — a class of molecules hypothesised to interact with chromatin to modulate gene expression. Derived from bronchial epithelial cells, Chonluten has been shown to suppress tumour necrosis factor (TNF) production in monocytes exposed to pro‑inflammatory bacterial lipopolysaccharide (LPS), essentially eliminating the immediate inflammatory response.

It also supports respiratory epithelial integrity by reducing intercellular gaps and accelerating mucosal repair. This makes Chonluten (20mg) research peptide a valuable tool for laboratories investigating respiratory biology, inflammation, oxidative stress, and epithelial barrier function.

At Wuhan Top Miracle Peptides, we supply high‑purity Chonluten (20mg) research peptide to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to ≥98% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into respiratory biology, inflammation, and bioregulation begin with uncompromising quality.

What Is Chonluten and How Does It Work?

To fully appreciate the research potential of Chonluten (20mg) research peptide, it is essential to understand its biochemical identity and the mechanisms by which it exerts its effects.

The EDG Tripeptide

Chonluten is a synthetic tripeptide consisting of three amino acids: glutamic acid, aspartic acid, and glycine — the sequence Glu‑Asp‑Gly (EDG). Its molecular formula is C₁₁H₁₇N₃O₈, and its molecular weight is approximately 319.27 g/mol. It is often described as having preferential activity in pulmonary tissues and, to a lesser extent, the gastrointestinal tract.

The peptide is classified among “cytogenetic peptides” or “bioregulators” — a set of short peptides hypothesised to modulate gene expression, particularly in cells of specialised tissues such as mucosal or epithelial systems. Within this framework, Chonluten is thought to support the expression of genes related to redox regulation, inflammation signalling, proliferation, and the maintenance of epithelial integrity.

Mechanism of Action: Anti‑Inflammatory and Epithelial Support

The biological activity of Chonluten (20mg) research peptide is mediated through several intersecting mechanisms:

Anti‑Inflammatory Factor Suppression

Chonluten acts on intracellular signalling pathways associated with inflammatory mediators. Research demonstrates that it suppresses TNF production in monocytes exposed to pro‑inflammatory bacterial LPS. This effectively limits both the intensity and duration of any given inflammatory reaction. The peptide inhibits core inflammatory pathways, particularly NF‑κB, and may also involve mitogen‑activated protein kinase (MAPK) signalling. The peptide also inhibits the expression of pro‑inflammatory IL‑6 cytokine stimulated by LPS.

Enhancing and Repairing Epithelial Barrier Function

Chonluten targets epithelial cells, promoting the expression and assembly of key proteins within tight junctions. By strengthening these structural junctions, it significantly reduces epithelial permeability, effectively blocking trans‑epithelial penetration of pathogens, allergens, and harmful substances. Simultaneously, epithelial cell migration and proliferation are stimulated, aiding in the more rapid repair of mucosal barriers.

Gene Expression and Epigenetic Modulation

It has been theorised that short peptides like Chonluten may enter nuclei and interact with promoter or suppressor regions of DNA, thereby altering transcriptional activity. Some proponents suggest that tripeptides may affect DNA methylation or histone modification, modifying accessibility of chromatin and thereby altering gene expression profiles. Chonluten is posited to support antioxidant gene systems, possibly upregulating SOD or glutathione regulatory genes in stressed epithelial cells.

Key Research Applications for Chonluten (20mg)

Chonluten (20mg) research peptide is a versatile tool with applications spanning several domains of biomedical research.

1. Respiratory Epithelium & Mucosal Research

One of the most compelling research areas for Chonluten is modelling the respiratory epithelium under stress. Research applications include:

• Airway Epithelial Cultures: Investigating shifts in gene expression of oxidative stress markers, mucin genes, tight junction proteins, or proliferation markers.

• Bronchial Epithelial Cell Biology: Studying the peptide’s role in supporting bronchial epithelial cell biology in preclinical research contexts.

• Epithelial Integrity: Investigating how Chonluten reduces intercellular gaps, maintaining epithelial integrity and reducing pathogen penetration.

• Mucosal Repair: Exploring how Chonluten accelerates mucosal repair following inflammation, infection, or physical injury.

2. Inflammation & Immunology Research

Chonluten’s potent anti‑inflammatory properties make it a valuable tool for studying inflammatory signalling. Research applications include:

• TNF Suppression: Investigating how Chonluten inhibits TNF production in monocytes exposed to LPS.

• Cytokine Signalling: Studying the inhibition of pro‑inflammatory IL‑6 cytokine.

• NF‑κB and MAPK Pathways: Exploring how Chonluten inhibits core inflammatory pathways.

• Macrophage Function: Investigating the role of Chonluten as a natural inducer of TNF tolerance in monocytes.

3. Redox Biology & Oxidative Stress Research

Chonluten is hypothesised to support antioxidant gene systems, positioning it as a tool for studying oxidative stress:

• Antioxidant Gene Upregulation: Investigating how Chonluten upregulates SOD or glutathione regulatory genes in stressed epithelial cells.

• Redox Balance: Studying how Chonluten tilts the redox balance toward a more reduced (less oxidative) microenvironment.

• Cell Survival and Repair: Exploring how redox modulation influences cell survival, repair, and proliferation pathways.

4. Gene Expression & Epigenetic Research

Chonluten serves as a model for studying how short peptides interact with chromatin and modulate gene expression:

• Promoter Docking: Investigating how short peptides may enter nuclei and interact with regulatory DNA regions.

• Chromatin Accessibility: Exploring how tripeptides may affect DNA methylation or histone modification.

• Gene Expression Profiling: Studying shifts in gene expression of oxidative stress markers, tight junction proteins, or proliferation markers.

5. Inflammatory‑Proliferative Axis Research

Chonluten is theorised to modulate the cross‑talk between inflammatory cytokine signalling and proliferative control:

• TNF‑α and COX‑2 Pathways: Investigating how Chonluten modulates inflammatory cytokine signalling.

• Proliferative Control: Exploring how Chonluten maintains sufficient proliferative signalling for regeneration while dampening excessive inflammatory responses.

Chemical & Physical Specifications

Accurate characterisation of Chonluten (20mg) research peptide is essential for reproducible experimental design.

Note: The 20 mg mass refers to the weight of the peptide in its lyophilised form. Chonluten is typically supplied as a TFA or acetate salt, which enhances aqueous solubility. The peptide belongs to the Khavinson family of short peptide bioregulators.

Reconstitution & Handling Protocol for Chonluten (20mg)

Proper reconstitution of Chonluten (20mg) research peptide is critical for maintaining its structural integrity and biological activity.

Step 1 – Preparation

• Bring the sealed Chonluten vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.

• Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.

Step 2 – Vial Sanitisation

• Wipe the rubber stopper of the Chonluten vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.

Step 3 – Reconstitution

• Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 20 mg per 2 mL of diluent, yielding a 10 mg/mL stock solution.

• Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.

• Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously, as shaking can cause denaturation.

Step 4 – Aliquoting & Storage

• Immediately after dissolution, aliquot the reconstituted Chonluten into single‑use sterile vials.

• Store aliquots at –20°C. Avoid repeated freeze‑thaw cycles, as peptides are susceptible to degradation.

• Once thawed, store at 2‑8°C and use within a short period.

Concentration Reference Table

Adjust diluent volume based on your experimental requirements. For cell culture applications, typical working concentrations may range from 0.1‑10 µM.

Storage & Stability Guidelines

Why Choose Wuhan Top Miracle Peptides for Chonluten (20mg)?

As an authentic licensed peptide supplier based in the United Kingdom, we supply Chonluten (20mg) research peptide and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).

• Verified Purity: Independent HPLC analysis with purity guaranteed ≥98% for every batch.

• GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.

• Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.

• Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.

• UK‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO).

Researchers across the United Kingdom—including those at leading institutions in London, Cambridge, Oxford, Manchester, and Edinburgh—trust us for fast domestic delivery, transparent documentation and professional technical support.

FAQ: Chonluten (20mg) Research Peptide

Q1: What is Chonluten (20mg) research peptide?
Chonluten is a synthetic tripeptide (Glu‑Asp‑Gly, EDG) belonging to the Khavinson family of short peptide bioregulators. It is derived from bronchial epithelial cells and is used in research to study respiratory biology, inflammation, oxidative stress, and epithelial barrier function.

Q2: What is the sequence and molecular weight of Chonluten?
The sequence is Glu‑Asp‑Gly (EDG). Its molecular formula is C₁₁H₁₇N₃O₈, and its molecular weight is approximately 319.27 g/mol.

Q3: What are the primary research applications for Chonluten?
Chonluten is used in respiratory epithelium and mucosal research, inflammation and immunology research (TNF suppression, cytokine signalling), redox biology and oxidative stress research, gene expression and epigenetic research, and inflammatory‑proliferative axis research.

Q4: What is the mechanism of action of Chonluten?
Chonluten suppresses TNF production in monocytes exposed to LPS, inhibits core inflammatory pathways including NF‑κB and MAPK, strengthens epithelial tight junctions, promotes epithelial repair, and is hypothesised to modulate gene expression through interactions with chromatin.

Q5: What purity does your Chonluten (20mg) meet?
Our Chonluten is tested to ≥98% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.

Q6: How should I reconstitute Chonluten (20mg)?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake. A typical starting concentration is 10 mg/mL.

Q7: How should I store reconstituted Chonluten?
Reconstituted Chonluten should be stored at 2‑8°C for short‑term use. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Avoid repeated freeze‑thaw cycles.

Q8: Is Chonluten research peptide legal to purchase in the UK?
Yes. Chonluten is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United Kingdom for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims.

Q9: Does Wuhan Top Miracle Peptides ship internationally?
Yes. We ship across the EU (France, Germany, Spain, Sweden, Italy) and to the USA from our UK warehouse. Wholesale pricing is available for bulk orders.

Final Thoughts

From its origin as a tripeptide derived from bronchial epithelial cells to its well‑characterised role in suppressing TNF production, inhibiting NF‑κB and MAPK pathways, and strengthening epithelial barrier function, Chonluten (20mg) research peptide provides a precisely defined and increasingly valuable platform for advanced respiratory and inflammatory research.

Its ability to modulate inflammatory signalling, support epithelial integrity, and potentially influence gene expression—supported by peer‑reviewed research published in PubMed and other authoritative journals—makes it a valuable addition to any laboratory investigating respiratory biology, inflammation, oxidative stress, or the molecular mechanisms of tissue bioregulation. By choosing high‑purity, lab‑verified Chonluten (20mg) research peptide from Wuhan Top Miracle Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.

Ready to advance your research with Chonluten (20mg)? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade Chonluten delivered directly to your facility in the UK, EU, or USA.